Georg S.
- Country
- Germany
- Department
- Opthalmology
Research Overview
- Dose-ranging study of FWY003 in geographic atrophy secondary to age-related macular degeneration: randomized, double-masked, placebo-controlled trial in adults
- Randomized, Double‑Masked, Multicenter Phase 2/3 Trial of Intravitreal MK‑8748 versus Aflibercept in Neovascular Age‑Related Macular Degeneration
- Evaluation of Efficacy and Safety of Intravitreal EYE103 Versus Ranibizumab in Diabetic Macular Edema: A Randomized, Double-Masked, Multi-Center Study
Data & Insights
Has run more than one trial at 148 of 251 partner sites.
Specializations
Retinal Vascular Disorders
This investigator specializes in treating macular edema caused by retinal vein occlusion, employing various therapeutic approaches including advanced intravitreal treatments and laser interventions.
- Central retinal vein occlusion management
- Innovative anti-VEGF therapies
- Targeted peripheral laser photocoagulation
The investigator explores combination treatments to optimize visual outcomes in patients with retinal vascular complications.
Age-Related Macular Degeneration
A significant focus of research lies in treating geographic atrophy, a severe form of age-related macular degeneration, through innovative therapeutic approaches.
- Complement inhibition therapies
- Novel intravitreal treatments
- Long-term disease management strategies
The investigator evaluates cutting-edge treatments targeting the progression of geographic atrophy.
Diabetic Eye Disease
The investigator conducts research in diabetic macular edema, evaluating new therapeutic agents and comparing their efficacy to established treatments.
- Visual acuity optimization
- Comparative treatment efficacy
- Advanced intravitreal therapeutics
Research focuses on innovative approaches to manage diabetic eye complications and improve visual outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.